Bluestein R H & CO LLC Dexcom Inc Transaction History

Bluestein R H & CO LLC

$1.61 Billion
Q3 2022

A detailed history of Bluestein R H & CO LLC transactions in Dexcom Inc stock. As of the latest transaction made, Bluestein R H & CO LLC holds 30,414 shares of DXCM stock, worth $2.22 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

30,414

Previous 30,980 1.83%

Holding current value

$2.22 Million

Previous $2.31 Million 6.11%

% of portfolio

0.15%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $43,214 - $53,305	-566 Reduced 1.83%	30,414 $2.45 Million
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $1.57 Million - $3.07 Million	23,067 Added 291.51%	30,980 $2.31 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $5.38 Million - $7.44 Million	-57,166 Reduced 87.84%	7,913 $4.05 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $56,623 - $70,989	436 Added 0.67%	65,079 $34.9 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $382,662 - $513,443	3,586 Added 5.87%	64,643 $35.4 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $305,980 - $407,759	3,778 Added 6.6%	61,057 $26.1 Million
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $933,707 - $1.15 Million	11,012 Added 23.8%	57,279 $20.6 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $430,872 - $577,258	5,524 Added 13.56%	46,267 $17.1 Million
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $14,899 - $17,620	-156 Reduced 0.38%	40,743 $16.8 Million
Q2 2020 Aug 12, 2020	BUY	$62.68 - $105.34 $505,576 - $849,672	8,066 Added 24.57%	40,899 $16.6 Million
Q1 2020 May 12, 2020	BUY	$47.79 - $75.63 $1.18 Million - $1.86 Million	24,596 Added 298.6%	32,833 $8.84 Million
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $21,422 - $33,514	-585 Reduced 6.63%	8,237 $1.8 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $8,100 - $9,986	-228 Reduced 2.52%	8,822 $1.32 Million
Q1 2019 May 10, 2019	SELL	$28.07 - $38.18 $1,403 - $1,909	-50 Reduced 0.55%	9,050 $1.08 Million
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $9,662 - $13,378	-358 Reduced 3.79%	9,100 $1.09 Million
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $186 - $293	-8 Reduced 0.08%	9,458 $1.35 Million
Q2 2018 Aug 10, 2018	BUY	$17.54 - $25.22 $15,628 - $22,471	891 Added 10.39%	9,466 $899,000
Q1 2018 May 10, 2018	SELL	$13.06 - $18.54 $1,959 - $2,781	-150 Reduced 1.72%	8,575 $636,000
Q3 2017 Nov 13, 2017	BUY	$11.36 - $18.98 $99,116 - $165,600	8,725	8,725 $427,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.

Account

Bluestein R H & CO LLC Dexcom Inc Transaction History